Cytokine mRNA expression in human epidermis after patch treatment with rhus and sodium lauryl sulfate

American Journal of Contact Dermatitis

Volumn 10, Issue 3, 1999, Pages 127-135

  Ryan, Cindy A ^a   Gerberick, G Frank ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PATCH TEST; POISON IVY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032835490     PISSN: 1046199X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-199X(99)90055-6     Document Type: Article

References (47)

1. Sauder DN, Pastore S: Cytokines in contact dermatitis. Am J Contact Dermat 4:215-224, 1993
2. Kimber I: Cytokines and regulation of allergic sensitization to chemicals. Toxicology 93:1-11, 1994
3. McKenzie RC, Sauder DN: The role of keratinocyte cytokines in inflammation and immunity. J Invest Derm 95:105-107, 1990 (suppl)
4. Barker JNWN: Role of keratinocytes in allergic contact dermatitis. Contact Dermatitis 26:145-148, 1992
5. Boehm KD, Yun JK, Strohl KP, et al: In situ changes in the relative abundance of epidermal cytokine messanger RNA levels following exposure to the poison ivy/oak contact allergen, urushiol. Exp Dermatol 5:150-160, 1996
6. Zepter K, Haffner A, Soohoo LF, et al: Induction of biologically active IL-1β-converting enzyme and mature IL-1β in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 159:6203-6208, 1997
7. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
8. Schreiber S, Kilgus O, Payer E, et al: Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 11:3525-3534, 1992
9. Enk AH, Angeloni VL, Udey MC, et al: An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 9:3698-3704, 1993
10. + T cells. Immunol Today 12:392-395, 1991
11. Hoefakker S, Caubo M, Van 'T Erve EHM, et al: In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 33:258-266, 1995
12. Macatonia SE, Edwards AJ, Knight SC: Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 59:509-514, 1986
13. Kinnaird A, Peters SW, Foster JR, et al: Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Appl Immunol 89:202-210, 1989
14. Witmer-Pack MD, Olivier W, Valinsky J, et al: Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484-1498, 1987
15. Heufler C, Koch F, Schuler G: Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700-705, 1988
16. Cumberbatch M, Kimber I: Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31-35, 1995
17. Knight SC, Krejci J, Malkovsky M, et al: The role of dendritic cells in the initiation of immune responses to contact sensitizers. Cell Immunol 94:427-434, 1985
18. Hauser C, Katz SI: Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc Natl Acad Sci USA 85:5625-5628, 1988
19. Fong TAT, Mosmann TR: The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 143:2887-2893, 1989
20. Gawkrodger DJ, McVittie E, Carr MM, et al: Phenotypic characterization of the early cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol 66:590-598, 1986
21. Scheynius A, Fischer T: Phenotypic difference between allergic and irritant patch test reactions in man. Contact Dermatitis 14:297-302, 1986
22. + cells in allergic versus irritant patch test responses. J Invest Dermatol 103:524-529, 1994
23. Kiistala U: Suction blister device for separation of viable epidermis from dermis. J Invest Derm 50:129-137, 1968
24. Mosmann TR, Cherwinski H, Bond MW, et al: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
25. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu RevImmunol 7:145-173, 1989
26. Mosmann TR: Regulation of immune responses by T cells with different cytokine secretion phenotypes: Role of a new cytokine, cytokine synthesis inhibitory factor (IL-10). Int Arch Allergy Appl Immunol 94:110-115, 1991
27. Cher DJ, Mosmann TR: Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 138:3688-3694, 1987
28. Hauser G: Cultured epidermal Langerhans cells activate effector T cells for contact sensitivity. J Invest Dermatol 95:436-440, 1990
29. Asherson GL, Dieli F, Sireci G, et al: Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 103:1-4, 1996
30. + T cells. J Exp Med 183:1001-1012, 1996
31. Asada H, Linton J, Katz SI: Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4. J Invest Dermatol 108:406-411, 1997
32. Kitagaki H, Ono N, Hayakawa K, et al: Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 159:2484-2491, 1997
33. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144:4121-4128, 1990
34. + T cell development from regulatory T helper to effector T Helper cells alters the contact hypersensitivity response. Eur J Immunol 26:2606-2612, 1996
35. + Th2 cells for contact hypersensitivity. J Immunol 159:4217-4226, 1997
36. Bouloc A, Cavani A, Katz SI: Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 111:44-49, 1998
37. Croft M, Carter L, Swain SL, et al: Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715-1728, 1994
38. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279, 1995
39. Gautam SC, Chikkala NF, Hamilton TA: Anti-inflammatory action of IL-5. Negative regulation of contact sensitivity to trinitrochlorobenzene. J Immunol 148:1411-1415, 1992
40. Ohmen JD, Hanifin JM, Nickoloff BJ, et al: Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154:1956-1963, 1995
41. Fiorentino DF, Zlotnik A, Vieira P, et al: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451, 1991
42. de Waal Malefyt R, Abrams J, Bennett B, et al: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
43. Enk AH, Katz SI: Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92-95, 1992
44. Kondo S, McKenzie RC, Sauder DN: Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103:811-814, 1994
45. Schwarz A, Grabbe S, Riemann H, et al: In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103:211-216, 1994
46. Kondo S, Pastore S, Shivji GM, et al: Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic dermatitis as well as irritant contact dermatitis in mouse skin. Lymph Cyto Res 13:367-375, 1994
47. Ferguson TA, Dube P, Griffith TS: Regulation of contact hypersensitivity by interleukin 10. J Exp Med 179:1597-1604, 1994